Neuropathy Clinical Trial
— N2OOfficial title:
A Retrospective Study of Neurological Impairment in a Young Population Exposed to Recreational Nitrous Oxide
Nitrous oxide (N2O) is a colorless, flammable, analgesic gas used in surgery and dentistry. The consumption of N2O has increased among young French people aiming to relax because of its short-lived neuropsychological effect (euphoria, depersonalization, analgesia) and its wide availability on the market. It can be responsible in case of prolonged use and overdose of a vitamin B12 deficiency with possible neuropsychiatric complications: sensitivomotor neuropathy, myelopathy, behavioral and cognitive disorders of acute or sub-acute installation. N2O inhibits the activitý of methionine synthase, decreases the activitý of methylmalonyl-CoA mutase leading to vitamin B12 deficiency but in addition to the interference with vitamin B12 metabolism there seems to be a direct toxicity of N20. Myelin alteration was the typical electromyography finding but new axonal profiles were also described. Since myelopathy affects both the posterior and lateral cords, combined spinal cord sclerosis is the most common location of injury associated with N2O intoxication.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | December 2024 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years and older |
Eligibility | patients presenting to the CHU of Nîmes with an acute or sub-acute neurological picture after having consumed N2O - |
Country | Name | City | State |
---|---|---|---|
France | CHU de Nîmes | Nîmes |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nimes |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | MRC score | MRCss - Medical Research Council sum score : This score assigns a rating to each muscle group: "0" = absence of visible contraction visible contractions, " 1 " = visible contractions without movement of limbs, " 2 " = insufficient 2" = insufficient movements to overcome weightlessness, "3" = movements to overcome weightlessness, "4" = movements against weightlessness and resistance, "5" = normal muscle strength. | baseline | |
Primary | Romberg score | A positive Romberg test means the presence of sensory ataxia | Baseline | |
Primary | INCAT Sensory Sum score (ISS) | grades from 0 (no involvement) to 20 (severe involvement) | Baseline | |
Primary | ONLS - Overall Neuropathy Limitations Scale | Overall Neuropathy Limitation Scale = arm scale (range 0 to 5) + leg scale (range 0 to 7); (range: 0 (no disability) to 12 (maximum disability) | Baseline | |
Primary | Rankin score | disability measurement score from 0 (none) to 6 (death) | Baseline | |
Primary | vitamin B12 level | vitamin B12 level in µmom/L | baseline | |
Primary | methyl malonic acid level | methyl-malonic acid level | baseline | |
Primary | electroneuromyogram | Normal Yes/No | baseline | |
Primary | Cerebral MRI | lesions yes/No | baseline | |
Primary | Pan-medullary MRI | lesions yes/No | baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03195868 -
Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy
|
N/A | |
Not yet recruiting |
NCT05565469 -
Correlation Between Abdominal Wall Stimulation and Neurostimulator Tip Location
|
N/A | |
Completed |
NCT02309164 -
The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).
|
N/A | |
Completed |
NCT00775645 -
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
|
Phase 3 | |
Completed |
NCT03624426 -
Detection and Prevention of Nerve Injury in Shoulder Arthroplasty Surgery
|
N/A | |
Withdrawn |
NCT03436680 -
Home-Based Neurofeedback Program in Treating Participants With Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
Completed |
NCT05691738 -
Effects of Modified Otago Exercises in Individuals With Diabetic Neuropathy
|
N/A | |
Completed |
NCT05095870 -
Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
|
||
Completed |
NCT02615678 -
Acupuncture for CIPN in Breast Cancer Patients
|
N/A | |
Completed |
NCT02011282 -
Electro-Neuro-Muscular Stimulation in ICU
|
N/A | |
Recruiting |
NCT01774058 -
The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation
|
Phase 2 | |
Completed |
NCT01135251 -
Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy
|
Phase 2 | |
Recruiting |
NCT06324344 -
Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN)
|
N/A | |
Recruiting |
NCT04403802 -
Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
Recruiting |
NCT04579406 -
Perioperative Adverse Cardiovascular Event in Type-2 Diabetic Patients
|
||
Recruiting |
NCT03881930 -
Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy
|
N/A | |
Completed |
NCT03909464 -
Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy
|
||
Completed |
NCT01523132 -
Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
|
N/A | |
Completed |
NCT02689661 -
Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects
|
||
Terminated |
NCT00998738 -
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
|
Phase 3 |